The Editorial Executive Committee welcomes letters, which should be less than 250 words. Before a decision to publish is made, letters which refer to a published article may be sent to the author for a response. Any letter may be sent to an expert for comment. When letters are published, they are usually accompanied in the same issue by their responses or comments. The Committee screens out discourteous, inaccurate or libellous statements. The letters are sub-edited before publication. Authors are required to declare any conflicts of interest. The Committee's decision on publication is final.

Withdrawal of useful drugs

Editor, – What can be done when a well-known and frequently recommended drug just fades out of sight because the manufacturers won't make it any more? One's suspicions run riot, including that it is too cheap to make and to sell, and the profit margin is therefore too small. Maybe they want to sell something similar but more profitable. Patients' needs and the needs of the Australian community in general seem to be of no consequence!

Donald B. Reid
General practitioner
Bridgetown, WA